524661 — Welcure Drugs and Pharmaceuticals Cashflow Statement
0.000.00%
Last trade - 00:00- IN₹988.75m
- IN₹986.59m
- 36
- 49
- 88
- 63
Annual cashflow statement for Welcure Drugs and Pharmaceuticals, fiscal year end - March 31st, INR millions except per share, conversion factor applied.
2020 March 31st | 2021 March 31st | 2022 March 31st | 2023 March 31st | 2024 March 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | ARS | ARS | ARS | ARS | ARS |
| Standards: | IAS | IAS | IAS | — | IAS |
| Status: | Final | Final | Final | Final | Final |
| Net Income/Starting Line | -0.094 | 0.551 | 0.236 | 1.02 | -1.75 |
| Depreciation | |||||
| Changes in Working Capital | -0.003 | -0.129 | -0.05 | 0.052 | 0.114 |
| Change in Other Assets | |||||
| Change in Other Liabilities | |||||
| Other Operating Cash Flow | |||||
| Cash from Operating Activities | -0.097 | 0.422 | 0.186 | 1.07 | -1.27 |
| Other Investing Cash Flow Items | 0 | 0 | 0 | 13.2 | 1.65 |
| Sale/Maturity of Investment | |||||
| Other Investing Cash Flow | |||||
| Cash from Investing Activities | 0 | 0 | 0 | 13.2 | 1.65 |
| Financing Cash Flow Items | 0 | 0 | 0 | -14.9 | -0.171 |
| Other Financing Cash Flow | |||||
| Cash from Financing Activities | 0 | 0 | 0 | -14.9 | -0.171 |
| Beginning Cash Balance | |||||
| Ending Cash Balance | |||||
| Net Change in Cash | -0.097 | 0.422 | 0.186 | -0.648 | 0.204 |